Drugs that contain Ibuprofen

1. Drug name - CALDOLOR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8735452 CUMBERLAND PHARMS Treating patients with intravenous ibuprofen Sep, 2029

(7 years from now)

US9649284 CUMBERLAND PHARMS Treating critically ill patients with intravenous ibuprofen Sep, 2029

(7 years from now)

US8871810 CUMBERLAND PHARMS Treating critically ill patients with intravenous ibuprofen Sep, 2029

(7 years from now)

US9114068 CUMBERLAND PHARMS Treating patients with intravenous ibuprofen Sep, 2029

(7 years from now)

US9295639 CUMBERLAND PHARMS Treating critically ill patients with intravenous ibuprofen Sep, 2029

(7 years from now)

US9138404 CUMBERLAND PHARMS Treating critically ill patients with intravenous ibuprofen Sep, 2029

(7 years from now)

US9012508 CUMBERLAND PHARMS Administration of intravenous ibuprofen Sep, 2030

(7 years from now)

US9072661 CUMBERLAND PHARMS Injectable ibuprofen formulation Mar, 2032

(9 years from now)

US9072710 CUMBERLAND PHARMS Injectable ibuprofen formulation Mar, 2032

(9 years from now)

Treatment: Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics, reduction in fever through anti-inflammatory, analgesic, and antipyretic activity; Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics in a critically ill patient with intravenous ibuprofen in need thereof; Methods of treating pain, inflammation and/or fever with intravenous ibuprofen such that mean arterial blood pressure does not increase the dosage interval; Methods of treating pain, inflammation and/or fever in a critically ill patient with intravenous ibuprofen in need thereof; Methods of treating pain, inflammation, fever, patent ductus arteriosis with aqueous composition; Methods of making aqueous composition and treating pain, inflammation, fever, patent ductus arteriosis with aqueous composition

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
400MG/4ML (100MG/ML) SOLUTION;INTRAVENOUS Discontinued
800MG/8ML (100MG/ML) SOLUTION;INTRAVENOUS Prescription
800MG/200ML (4MG/ML) SOLUTION;INTRAVENOUS Prescription

2. Drug name - CHILDREN'S ADVIL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10238640 GLAXOSMITHKLINE Pharmaceutical suspension composition May, 2024

(1 year, 7 months from now)

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
100MG/5ML SUSPENSION;ORAL Over the counter

availability in other generic markets.

Click on the highlighted region to filter.